<DOC>
	<DOCNO>NCT02244307</DOCNO>
	<brief_summary>The primary objective observational study assessment prognosis factor recourse prostatic surgery patient BPH administer class-1 alpha blocker . The secondary objective assessment time alpha-adrenergic blockade treatment initiation surgery evolution patient study .</brief_summary>
	<brief_title>Observational Study Patients Suffering From Benign Prostatic Hyperplasia Treated With Alpha-adrenergic Blockade</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Adrenergic Antagonists</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<criteria>Any patient BPH alphablocker treatment indicated Patients already class1 alphablockers participate study information require know and/or available Patient 's followup possible Patients participate another study History BPH surgery Prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>